LIXT
Price
$3.61
Change
+$0.27 (+8.08%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
29.07M
Intraday BUY SELL Signals
PVCT
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jan 13 closing price
Capitalization
25.74M
Intraday BUY SELL Signals
Interact to see
Advertisement

LIXT vs PVCT

Header iconLIXT vs PVCT Comparison
Open Charts LIXT vs PVCTBanner chart's image
Lixte Biotechnology Holdings
Price$3.61
Change+$0.27 (+8.08%)
Volume$100
Capitalization29.07M
Provectus Biopharmaceuticals
Price$0.06
Change-$0.00 (-0.00%)
Volume$59.5K
Capitalization25.74M
LIXT vs PVCT Comparison Chart in %
LIXT
Daily Signal:
Gain/Loss:
PVCT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LIXT vs. PVCT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIXT is a Hold and PVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LIXT: $3.34 vs. PVCT: $0.06)
Brand notoriety: LIXT and PVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIXT: 86% vs. PVCT: 25%
Market capitalization -- LIXT: $29.07M vs. PVCT: $25.74M
LIXT [@Biotechnology] is valued at $29.07M. PVCT’s [@Biotechnology] market capitalization is $25.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIXT’s FA Score shows that 0 FA rating(s) are green whilePVCT’s FA Score has 1 green FA rating(s).

  • LIXT’s FA Score: 0 green, 5 red.
  • PVCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PVCT is a better buy in the long-term than LIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIXT’s TA Score shows that 3 TA indicator(s) are bullish while PVCT’s TA Score has 2 bullish TA indicator(s).

  • LIXT’s TA Score: 3 bullish, 5 bearish.
  • PVCT’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, PVCT is a better buy in the short-term than LIXT.

Price Growth

LIXT (@Biotechnology) experienced а -6.18% price change this week, while PVCT (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIXT($29.1M) has a higher market cap than PVCT($25.7M). PVCT YTD gains are higher at: 9.571 vs. LIXT (-15.013). LIXT has higher annual earnings (EBITDA): -4.07M vs. PVCT (-6.51M). LIXT has more cash in the bank: 5.34M vs. PVCT (72.5K). LIXT has less debt than PVCT: LIXT (100K) vs PVCT (2.44M). LIXT (0) and PVCT (0) have equivalent revenues.
LIXTPVCTLIXT / PVCT
Capitalization29.1M25.7M113%
EBITDA-4.07M-6.51M63%
Gain YTD-15.0139.571-157%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.34M72.5K7,368%
Total Debt100K2.44M4%
FUNDAMENTALS RATINGS
LIXT vs PVCT: Fundamental Ratings
LIXT
PVCT
OUTLOOK RATING
1..100
7952
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6381
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is somewhat better than the same rating for LIXT (52). This means that PVCT’s stock grew somewhat faster than LIXT’s over the last 12 months.

PVCT's Profit vs Risk Rating (99) in the null industry is in the same range as LIXT (100). This means that PVCT’s stock grew similarly to LIXT’s over the last 12 months.

PVCT's SMR Rating (100) in the null industry is in the same range as LIXT (100). This means that PVCT’s stock grew similarly to LIXT’s over the last 12 months.

LIXT's Price Growth Rating (63) in the null industry is in the same range as PVCT (81). This means that LIXT’s stock grew similarly to PVCT’s over the last 12 months.

LIXT's P/E Growth Rating (100) in the null industry is in the same range as PVCT (100). This means that LIXT’s stock grew similarly to PVCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIXTPVCT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LIXT
Daily Signal:
Gain/Loss:
PVCT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNCJF0.10N/A
N/A
Fancamp Exploration Ltd.
MAWHF0.62N/A
N/A
Man Wah Holdings, Ltd.
AIMUF6.00N/A
N/A
Aimfinity Investment Corp. I
ALLDF13.55N/A
N/A
ALD S A
KPGHF5.72-0.06
-1.04%
Kelly Partners Group Holdings Ltd.

LIXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIXT has been loosely correlated with PTHS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIXT jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-1.76%
PTHS - LIXT
34%
Loosely correlated
-1.31%
NTLA - LIXT
28%
Poorly correlated
+2.71%
IBIO - LIXT
28%
Poorly correlated
-5.93%
BBIO - LIXT
27%
Poorly correlated
+2.95%
PMN - LIXT
26%
Poorly correlated
-0.61%
More

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and LABFF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
-0.91%
LABFF - PVCT
23%
Poorly correlated
N/A
RVPH - PVCT
20%
Poorly correlated
+9.23%
PPTDF - PVCT
17%
Poorly correlated
N/A
PRRUF - PVCT
11%
Poorly correlated
N/A
LIXT - PVCT
10%
Poorly correlated
-1.76%
More